← Back to headlines
Silence Therapeutics Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential
Silence Therapeutics plc (SLN) has been initiated at an 'Overweight' rating by an analyst who emphasizes the potential of its siRNA pipeline.
30 Jun, 13:06 — 30 Jun, 13:06
Sources
Showing 1 of 1 sources
Related Stories
Fired Military Newspaper Journalists Sue Pentagon Over Firings
33m ago
Deadly Himalayan Floods From Glacier Collapse Kill Hundreds Across Nepal and Tibet
42m ago
Violent Clashes Erupt in Spanish Enclave of Ceuta After Migrant Camp Burnings
46m ago
Iran Denies Alleged Assassination Plot Targeting Trump's Son
1h ago